UMIN-CTR Clinical Trial

Recruitment status Terminated
Unique ID issued by UMIN UMIN000007467
Receipt No. R000008805
Official scientific title of the study The prevntional effect of celecoxib on acute pancreatitis after endoscopic retrograde cholangiopancreatography.
Date of disclosure of the study information 2012/04/01
Last modified on 2018/03/12 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study The prevntional effect of celecoxib on acute pancreatitis after endoscopic retrograde cholangiopancreatography.
Title of the study (Brief title) The preventional effect of celecoxib on acute pancreatitis after endoscopic retrograde cholangiopancreatography.
Region
Japan

Condition
Condition acute pancreatitis after endoscopic retrograde cholangiopancreatography
Classification by specialty
Hepato-biliary-pancreatic medicine Hepato-biliary-pancreatic surgery
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 We will invesigate the preventional effect of celecoxib on acute pancreatitis after endoscopic retrograde cholangiopancreatography
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2
Developmental phase Not applicable

Assessment
Primary outcomes 1:incidence rate of acute pancreatitis
2:serum amylase level
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control No treatment
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Prevention
Type of intervention
Medicine
Interventions/Control_1 celecoxib fo oral administration
Interventions/Control_2 no treatment
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit
85 years-old >=
Gender Male and Female
Key inclusion criteria all patients who are examined endoscopic retrograde cholangiopancreatography
Key exclusion criteria digestive organ ulcer
Target sample size 50

Research contact person
Name of lead principal investigator Adachi Tomohiko
Organization Nagasaki University
Division name department of surgery
Address 1-7-1 Sakamoto Nagasaki
TEL 095-819-7316
Email adatomo-ngs@umin.net

Public contact
Name of contact person Tomohiko Adachi
Organization University of Nagasaki
Division name department surgery
Address 1-7-1, Sakamoto, Nagasaki
TEL 095-819-7316
Homepage URL
Email adatomo@nifty.com

Sponsor
Institute Depatment of surgery
University of Nagasaki
Institute
Department

Funding Source
Organization none
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2012 Year 04 Month 01 Day

Progress
Recruitment status Terminated
Date of protocol fixation
2012 Year 01 Month 01 Day
Anticipated trial start date
2012 Year 04 Month 01 Day
Last follow-up date
2018 Year 03 Month 01 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2012 Year 03 Month 07 Day
Last modified on
2018 Year 03 Month 12 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000008805